Picture of China Resources Pharmaceutical logo

3320 — China Resources Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million

April 24 (Reuters) - China Resources Boya Bio pharmaceutical Group Co Ltd 300294.SZ:

CR BOYA BIO-PHARMACEUTICAL QTRLY UNAUDITED REVENUE RMB 321.1 MILLION, NET PROFIT RMB 30.0 MILLION

Further company coverage: 300294.SZ

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on China Resources Pharmaceutical

See all news